Fasting Before a DEXA Scan: Is It Required?

What a DEXA scan actually measures

DEXA measures areal bone mineral density (grams per square centimeter) at the lumbar spine, femoral neck, and total hip by comparing the attenuation of two X-ray energy beams as they pass through bone and soft tissue. It is a body-composition and bone-density imaging technique, not a blood test, and it carries no dietary preparation requirement in the way a fasting lipid panel does.

T-score versus Z-score

The T-score compares your BMD to a young-adult, same-sex reference population and is the basis for the WHO diagnostic categories below. The Z-score compares you to age- and sex-matched peers and is the more appropriate metric in premenopausal women and men under 50. A markedly low Z-score in a younger patient is generally treated as a signal to look for a secondary cause of bone loss (endocrine disease, malabsorption, medication effect) rather than as evidence of ordinary age-related decline.

WHO diagnostic categories

This classification is the standard clinical framework used to interpret DEXA reports in postmenopausal women and older men. It was not designed to set a personal "optimal" target above the normal cutoff, and the specific numeric fracture-risk percentages sometimes attached to each category vary by calculator (such as FRAX) and by population; a reader who wants a personalized fracture-risk estimate should ask their clinician to run one rather than relying on a generic percentage.

The core, quotable answer: DEXA-measured bone density is affected by nutrition in two distinct ways, chronic calcium, vitamin D, and protein intake shape true long-term bone mass, while acute factors such as a same-day calcium supplement, a large recent weight change, or metal over the scan field can distort a single reading without any real change in bone; fasting itself is not required for an accurate DEXA scan.

Calcium: the nutrient with the clearest scan-day effect

The NIH Office of Dietary Supplements sets the calcium RDA at 1,000 mg/day for adults 19-50, rising to 1,200 mg/day for women 51 and older and men 71 and older. Chronic calcium deficiency is one of the best-established modifiable contributors to low bone mass; large randomized calcium-plus-vitamin-D trials in postmenopausal women have generally reported small but real improvements in hip and spine BMD compared with placebo, with the greatest benefit in participants who were calcium-deficient at baseline. Exact effect sizes from any single trial should be checked against the primary publication before being repeated as a precise number, since trial results vary by dose, adherence, and baseline status.

Dietary calcium (dairy, fortified foods, leafy greens) is absorbed at roughly 30 to 35 percent. Calcium carbonate supplements need stomach acid and work best taken with food; calcium citrate does not depend on meals. Because absorption saturates above roughly 500 mg per dose, splitting supplemental calcium into two smaller doses is generally preferred over one large dose, per NIH guidance.

The pre-scan caveat

A calcium supplement or calcium-containing antacid taken shortly before a DEXA scan can still be sitting in the gastrointestinal tract during imaging, where its density can be picked up in the lumbar spine field and inflate the apparent BMD reading. Holding calcium supplements for at least several hours before the scan is common clinical practice; no full caloric fast is needed. If you are unsure how long to hold your specific supplement, ask the scheduling facility, since practice varies slightly by site.

Vitamin D: the absorption gatekeeper

Vitamin D is required for intestinal calcium absorption. When circulating 25-hydroxyvitamin D is low, the body compensates by raising parathyroid hormone (PTH), which pulls calcium out of bone to maintain blood calcium levels, a process called secondary hyperparathyroidism. Chronically elevated PTH preferentially erodes trabecular bone, which is concentrated in the lumbar spine, one of the two sites DEXA measures most sensitively.

Clinical guidelines commonly define vitamin D deficiency as a level below 20 ng/mL and insufficiency between 20 and 29 ng/mL, with many clinicians targeting levels above 30 ng/mL for skeletal health; some target a higher range for other reasons. These specific cutoffs are guideline-derived rather than universally fixed, and a reader with a borderline result should discuss the target range with their own clinician rather than apply a single number.

Protein: an underappreciated bone nutrient

Roughly 30 percent of bone matrix is organic material, and type I collagen makes up most of that fraction. Adequate dietary protein supports collagen synthesis and IGF-1 signaling, both of which support osteoblast (bone-building) activity. Observational cohort studies have reported an association between higher dietary protein intake and higher femoral neck BMD in older adults, and the older concern that high protein intake "leaches" calcium from bone through an acid load has largely not held up when calcium intake is adequate. A commonly cited practical target for adults over 50 is roughly 1.0 to 1.2 g of protein per kg body weight per day, though this figure should be treated as a general dietary guideline rather than a prescription, and individual protein needs vary with kidney function, body composition, and activity level.

Other dietary factors with weaker or mixed evidence

Sodium. High sodium intake increases urinary calcium excretion (a "renal calcium leak"). Over years this chronic loss is plausible as a contributor to lower BMD, particularly in postmenopausal women, though the size of the effect at typical dietary sodium intakes is not as firmly established as the calcium and vitamin D relationships above.

Caffeine. Caffeine intake above roughly 400 mg/day modestly increases urinary calcium excretion. Cohort data suggest this effect is largely offset when dietary calcium intake is adequate, so moderate coffee intake (roughly four or fewer standard cups daily) is not considered a meaningful independent bone-loss risk in people meeting their calcium requirement.

Alcohol. Alcohol suppresses osteoblast activity directly, and chronic heavy intake is recognized as one of the more common causes of secondary osteoporosis, particularly in men, according to public health guidance on alcohol and bone health.

Magnesium. Magnesium is a cofactor for both PTH secretion and vitamin D activation, and deficiency can impair both processes. The RDA is 420 mg/day for men and 320 mg/day for women, per NIH Office of Dietary Supplements.

Vitamin K2 and sugar-sweetened beverages. Vitamin K2 (menaquinone) is involved in activating osteocalcin, a protein that helps anchor calcium into bone matrix, and cola-type sugar-sweetened beverages have been associated with lower BMD in some cohort studies, possibly related to phosphoric acid or to substituting soda for calcium-containing drinks. Both areas have supportive but less definitive evidence than calcium, vitamin D, and protein, and specific effect sizes reported in individual studies should be verified against the primary paper before being treated as established.

Mediterranean-pattern eating. A dietary pattern combining adequate calcium sources, anti-inflammatory foods, and higher potassium intake is plausibly protective for bone, and some trial and cohort data support a slower rate of lumbar spine BMD decline with adherence to this pattern, particularly when combined with structured physical activity. Because these interventions typically bundle diet with exercise and weight management, the bone benefit should not be attributed to diet in isolation.

Fasting and meal timing: what actually changes DEXA accuracy

DEXA does not require a caloric fast because it measures X-ray attenuation, not a blood analyte. Two things do matter:

Calcium supplements before the scan. As above, hold calcium supplements and calcium-containing antacids for at least several hours before scanning to avoid a false elevation in lumbar spine density.

Weight change between scans. DEXA reports an area-density value (g/cm²) derived partly from a soft-tissue correction algorithm. A large weight change since your last scan (commonly cited as more than roughly 10 percent of body weight) can shift this correction enough to make serial comparisons less reliable. For longitudinal monitoring, scanning at a similar body weight, at the same facility, and on the same machine improves comparability. If your weight has changed substantially, tell the technologist before the scan so it can be noted on the report.

Clothing and metal. Belts, underwire bras, and metal jewelry over the scan field can artificially raise apparent BMD at the lumbar spine by a clinically meaningful margin. This is not a nutrition variable, but in practice it is one of the most common preventable sources of scan error.

Decision framework: what changes before your scan, and what does not

Not every nutrition-related factor deserves the same response. This framework separates same-day scan-accuracy issues from long-term bone-health issues, so you know which ones need action before your appointment and which ones are a longer conversation with your clinician.

If you took a calcium supplement or calcium antacid this morning, hold future doses until after the scan is complete; call the facility if you are unsure whether today's dose will affect the reading, since holding intervals vary slightly by site.

If your weight has changed by more than roughly 10 percent since your last DEXA, flag this to the technologist before scanning. The comparison to your prior scan may be less reliable, and your clinician may want to interpret the trend cautiously rather than as a definitive change in bone status.

If you are vitamin D deficient or have never been tested, a DEXA scan will still run normally, but a low bone density reading in this setting may partly reflect reversible secondary hyperparathyroidism rather than permanent bone loss. This is a reason to test and correct vitamin D status and consider rescanning later, not a reason to postpone today's scan.

If you are on chronic glucocorticoids, aromatase inhibitors, GnRH agonists, or suppressive-dose levothyroxine, these medications are recognized causes of accelerated bone loss independent of diet. Bring a full medication list to your ordering clinician; nutrition optimization is additive to, not a substitute for, monitoring and treatment decisions made with your prescriber.

If your T-score is in the osteoporosis range or you have had a fragility fracture, nutrition changes alone (calcium, vitamin D, protein) are unlikely to reverse an existing osteoporosis diagnosis. This is the point at which pharmacologic therapy is typically discussed with a clinician; nutrition and resistance exercise support that treatment rather than replace it.

If you are premenopausal or a man under 50 with a low Z-score, this pattern is usually treated as a signal to investigate secondary causes (endocrine, gastrointestinal, medication-related) rather than to assume ordinary bone aging. Nutrition history is one part of that workup, not the whole of it.

If you simply want to know whether you need to fast, no. Eat normally. Only hold calcium supplements, and remove metal and dense clothing from the scan field.

Medications that change bone density independent of diet

Chronic glucocorticoid use (commonly cited threshold: prednisone at or above 5 mg/day for more than three months) is a well-recognized cause of medication-induced osteoporosis, and clinical guidance generally recommends baseline and follow-up DEXA plus adequate calcium and vitamin D intake in patients on long-term glucocorticoids. Aromatase inhibitors (used in breast cancer treatment) and GnRH agonists (used in prostate cancer treatment) suppress sex hormones and are associated with accelerated bone loss during treatment. Suppressive-dose levothyroxine (used in some thyroid cancer survivors) is also associated with increased bone turnover. In all of these situations, nutrition support is a component of bone monitoring, not a substitute for the monitoring itself.

Hormones and the limits of nutrition alone

Estrogen restrains bone resorption, and bone turnover accelerates in the years around menopause; large randomized trial data have shown that estrogen therapy reduces hip fracture risk in postmenopausal women, though the exact magnitude reported in any single trial should be checked against the primary source rather than repeated as a fixed figure. Similarly, testosterone deficiency in men is associated with lower spine and hip BMD, and testosterone replacement studies have reported meaningful increases in lumbar spine density over roughly a year of treatment. In both sexes, adequate calcium, vitamin D, and protein intake support the response to hormone therapy, but they do not reproduce the effect of the hormone itself in someone who is deficient.

What is established, what is plausible, and what is not

Established: WHO T-score categories are the standard clinical framework for interpreting DEXA in postmenopausal women and men 50 and older. Calcium and vitamin D deficiency reduce bone density through well-understood mechanisms (reduced absorption, secondary hyperparathyroidism). A same-day calcium supplement or metal over the scan field can distort a single reading. Chronic heavy alcohol use and long-term glucocorticoid therapy are recognized causes of bone loss. Fasting is not required for DEXA.

Plausible but not firmly quantified from the material available here: the precise size of BMD improvement from calcium/vitamin D supplementation, the exact protein-dose-response relationship with BMD, the magnitude of sodium-driven calcium loss at typical dietary intakes, and the independent contribution of a Mediterranean dietary pattern versus the exercise and weight-management components usually bundled with it in trials.

Not established from this material: a specific percentage reduction in fracture risk attributable to any single nutrient in isolation, a validated "optimal" T-score target above the WHO normal range, and any individualized dosing recommendation for calcium, vitamin D, or protein, those require a clinician who has your labs, medication list, and fracture history.